Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.

Increased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expre...

Full description

Bibliographic Details
Main Authors: Aaron Erdely, Diane Kepka-Lenhart, Rebecca Salmen-Muniz, Rebecca Chapman, Tracy Hulderman, Michael Kashon, Petia P Simeonova, Sidney M Morris
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-12-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2997799?pdf=render
id doaj-b2109f69e19940a980124f78779c1f2a
record_format Article
spelling doaj-b2109f69e19940a980124f78779c1f2a2020-11-25T01:18:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-12-01512e1525310.1371/journal.pone.0015253Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.Aaron ErdelyDiane Kepka-LenhartRebecca Salmen-MunizRebecca ChapmanTracy HuldermanMichael KashonPetia P SimeonovaSidney M MorrisIncreased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expression and arginine metabolism in specific blood vessels, there is no information regarding the impact of lipid diets on arginase activity or arginine bioavailability at a systemic level. We, therefore, evaluated the effects of high fat (HF) and high fat-high cholesterol (HC) diets on arginase activity in plasma and tissues and on global arginine bioavailability (defined as the ratio of plasma arginine to ornithine + citrulline) in apoE(-/-) and wild-type C57BL/6J mice. HC and HF diets led to reduced global arginine bioavailability in both strains. The HC diet resulted in significantly elevated plasma arginase in both strains, but the HF diet increased plasma arginase only in apoE(-/-) mice. Elevated plasma arginase activity correlated closely with increased alanine aminotransferase levels, indicating that liver damage was primarily responsible for elevated plasma arginase. The HC diet, which promotes atherogenesis, also resulted in increased arginase activity and expression of the type II isozyme of arginase in multiple tissues of apoE(-/-) mice only. These results raise the possibility that systemic changes in arginase activity and global arginine bioavailability may be contributing factors in the initiation and/or progression of cardiovascular disease.http://europepmc.org/articles/PMC2997799?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Aaron Erdely
Diane Kepka-Lenhart
Rebecca Salmen-Muniz
Rebecca Chapman
Tracy Hulderman
Michael Kashon
Petia P Simeonova
Sidney M Morris
spellingShingle Aaron Erdely
Diane Kepka-Lenhart
Rebecca Salmen-Muniz
Rebecca Chapman
Tracy Hulderman
Michael Kashon
Petia P Simeonova
Sidney M Morris
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
PLoS ONE
author_facet Aaron Erdely
Diane Kepka-Lenhart
Rebecca Salmen-Muniz
Rebecca Chapman
Tracy Hulderman
Michael Kashon
Petia P Simeonova
Sidney M Morris
author_sort Aaron Erdely
title Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
title_short Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
title_full Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
title_fullStr Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
title_full_unstemmed Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
title_sort arginase activities and global arginine bioavailability in wild-type and apoe-deficient mice: responses to high fat and high cholesterol diets.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2010-12-01
description Increased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expression and arginine metabolism in specific blood vessels, there is no information regarding the impact of lipid diets on arginase activity or arginine bioavailability at a systemic level. We, therefore, evaluated the effects of high fat (HF) and high fat-high cholesterol (HC) diets on arginase activity in plasma and tissues and on global arginine bioavailability (defined as the ratio of plasma arginine to ornithine + citrulline) in apoE(-/-) and wild-type C57BL/6J mice. HC and HF diets led to reduced global arginine bioavailability in both strains. The HC diet resulted in significantly elevated plasma arginase in both strains, but the HF diet increased plasma arginase only in apoE(-/-) mice. Elevated plasma arginase activity correlated closely with increased alanine aminotransferase levels, indicating that liver damage was primarily responsible for elevated plasma arginase. The HC diet, which promotes atherogenesis, also resulted in increased arginase activity and expression of the type II isozyme of arginase in multiple tissues of apoE(-/-) mice only. These results raise the possibility that systemic changes in arginase activity and global arginine bioavailability may be contributing factors in the initiation and/or progression of cardiovascular disease.
url http://europepmc.org/articles/PMC2997799?pdf=render
work_keys_str_mv AT aaronerdely arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT dianekepkalenhart arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT rebeccasalmenmuniz arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT rebeccachapman arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT tracyhulderman arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT michaelkashon arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT petiapsimeonova arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
AT sidneymmorris arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets
_version_ 1725140370800508928